Jane Street Group, LLC Beyond Spring Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.56 - $2.61 $31,056 - $144,745	55,458 New	55,458 $104,000
Q2 2022 Aug 16, 2022	SELL	$1.13 - $2.66 $27,245 - $64,135	-24,111 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$1.68 - $5.01 $65,345 - $194,868	-38,896 Reduced 61.73%	24,111 $53,000
Q4 2021 Feb 15, 2022	SELL	$4.02 - $16.84 $236,170 - $989,333	-58,749 Reduced 48.25%	63,007 $285,000
Q3 2021 Nov 16, 2021	BUY	$9.26 - $31.31 $1.13 Million - $3.81 Million	121,756 New	121,756 $1.92 Million
Q1 2021 May 18, 2021	SELL	$10.61 - $15.77 $154,131 - $229,090	-14,527 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$10.21 - $17.31 $148,320 - $251,462	14,527 New	14,527 $177,000

5.77M

53.2K

2.5K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $91.5M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.